Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Lorusso, D; Ferrandina, G; Colombo, N; Pignata, S; Pietragalla, A; Sonetto, C; Pisano, C; Lapresa, Mt; Savarese, A; Tagliaferri, P; Lombardi, D; Cinieri, S; Breda, E; Sabatucci, I; Sabbatini, R; Conte, C; Cecere, Sc; Maltese, G; Scambia, G.